Sumanirole - Pfizer
Alternative Names: PNU 95666; U 95666Latest Information Update: 15 Nov 2005
Price :
$50 *
At a glance
- Originator Pfizer
- Class Antiparkinsonians; Anxiolytics; Neuroprotectants
- Mechanism of Action 5-HT1A serotonin receptor agonists; Dopamine D2 receptor agonists; Serotonin 1D receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 15 Nov 2005 Data from preclinical studies have been added to the Parkinson's Disease and Movement Disorders pharmacodynamics section ,
- 23 Jul 2004 Discontinued - Phase-II for Parkinson's disease in Japan (unspecified route)
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer